These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36101398)

  • 1. Roles of Natriuretic Peptides and the Significance of Neprilysin in Cardiovascular Diseases.
    Nakagawa H; Saito Y
    Biology (Basel); 2022 Jul; 11(7):. PubMed ID: 36101398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
    Wegner M; Ganten D; Stasch JP
    Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral endopeptidase (CD10) is abundantly expressed in the epididymis and localized to a distinct population of epithelial cells--its relevance for CNP degradation.
    Thong A; Müller D; Feuerstacke C; Mietens A; Stammler A; Middendorff R
    Mol Cell Endocrinol; 2014 Jan; 382(1):234-243. PubMed ID: 24099862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanism of Blood Pressure Regulation through the Atrial Natriuretic Peptide.
    Tokudome T; Otani K
    Biology (Basel); 2022 Sep; 11(9):. PubMed ID: 36138830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
    Hamad AM; Range S; Holland E; Knox AJ
    Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renal and cardiovascular effects of natriuretic peptides.
    Wong PC; Guo J; Zhang A
    Adv Physiol Educ; 2017 Jun; 41(2):179-185. PubMed ID: 28377431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin Receptor-Neprilysin Inhibitors and the Natriuretic Peptide Axis.
    Vasquez N; Carter S; Grodin JL
    Curr Heart Fail Rep; 2020 Jun; 17(3):67-76. PubMed ID: 32394149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation.
    Dickey DM; Potter LR
    J Mol Cell Cardiol; 2011 Jul; 51(1):67-71. PubMed ID: 21459096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.
    Fu S; Ping P; Wang F; Luo L
    J Biol Eng; 2018; 12():2. PubMed ID: 29344085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
    Chen HH; Burnett JC
    Proc Assoc Am Physicians; 1999; 111(5):406-16. PubMed ID: 10519161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial permeability in vitro and in vivo: protective actions of ANP and omapatrilat in experimental atherosclerosis.
    Ichiki T; Izumi R; Cataliotti A; Larsen AM; Sandberg SM; Burnett JC
    Peptides; 2013 Oct; 48():21-6. PubMed ID: 23927843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
    Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
    JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular physiology of natriuretic peptide signalling.
    Kuhn M
    Basic Res Cardiol; 2004 Mar; 99(2):76-82. PubMed ID: 14963665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
    Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
    Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine and paracrine actions of natriuretic peptides in the heart.
    D'Souza SP; Davis M; Baxter GF
    Pharmacol Ther; 2004 Feb; 101(2):113-29. PubMed ID: 14761702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide.
    Walther T; Stepan H; Pankow K; Becker M; Schultheiss HP; Siems WE
    Biol Chem; 2004 Feb; 385(2):179-84. PubMed ID: 15101560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional compartmentation of the endocrine action of cardiac natriuretic peptides].
    Haloui M; Arnal JF; Pham I; Gonzalez W; Lyoussi B; Michel JB
    Ann Endocrinol (Paris); 2000 Feb; 61(1):32-40. PubMed ID: 10790590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line.
    Suda M; Tanaka K; Yasoda A; Komatsu Y; Chusho H; Miura M; Tamura N; Ogawa Y; Nakao K
    J Bone Miner Metab; 2002; 20(3):136-41. PubMed ID: 11984695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac and intestinal natriuretic peptides: insights from genetically modified mice.
    Kuhn M
    Peptides; 2005 Jun; 26(6):1078-85. PubMed ID: 15911075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.
    Nougué H; Pezel T; Picard F; Sadoune M; Arrigo M; Beauvais F; Launay JM; Cohen-Solal A; Vodovar N; Logeart D
    Eur J Heart Fail; 2019 May; 21(5):598-605. PubMed ID: 30520545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.